According to the Univdatos, the increased prevalence of PTC, and the rising healthcare expenditures drive the pseudotumor cerebri market. As per their “Pseudotumor cerebri Market” report, the global market was valued at USD ~3.2 billion in 2023, growing at a CAGR of about 5.5% during the forecast period from 2024 - 2032 to reach USD billion by 2032.

Introduction

Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is a neurological disorder in which the pressure that surrounds the brain and spinal cord (intracranial pressure) is higher than normal, but there is no inflammation, infection, tumor, or other conditions that can explain this increase. This condition is more prevalent in pregnant women and women of childbearing age with excess body weight or obesity. The exact etiology has yet to be ascertained although it is likely related to a malfunction in the regulation of CSF. The early symptoms are usually chronic headaches, and changes in vision, for example, blurring, diplopia or temporary loss of vision, pulsating tinnitus, and increased intracranial pressure papilledema. If left untreated may lead to permanent blindness. Diagnostics consists of clinical examination and assessment, brain imaging to rule in and out other pathological possibilities, and obtaining CSF pressure by lumbar puncture. Management involves a reduction of intracranial pressure, for which some patients may be recommended to lose weight, take medications, particularly acetazolamide, undertake optic nerve sheath fenestration, or spinal fluid shunt should be used if the condition becomes extreme.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/Pseudotumor-Cerebri-Market?popup=report-enquiry

Increasing obesity cases is driving high demand in North America

The North American Pseudotumor cerebri market grows due to higher obesity levels which are known to cause the condition. Pseudotumor cerebri affects obese patients mostly those of childbearing age in the female gender. More people develop Pseudotumor cerebri in North America because they become obese through excessive screen time and poor eating habits along with minimal physical activity. According to the CDC, 42% of adults in the United States are obese, which shows this problem affects large numbers of people across the nation. The worldwide increase in patients with Pseudotumor cerebri generates demand for improved diagnostic methods and better management methods to treat this condition. More medical professionals and patients now recognize Pseudotumor cerebri which helps them make correct diagnoses in the early phase so that the patients can get better treatment results and grow the market further. Doctors now have better medical devices for minimally invasive surgery while pharmaceutical experts develop new medicines coupled with advanced imaging systems that boost market growth. North America offers strong market expansion opportunities because it has developed healthcare systems along with large investments from pharmaceutical and medical device companies in research. The market expects steady growth because the region deals with many obesity-related Pseudotumor cerebri cases.

For instance, new CDC population data from 2023 show that in 23 states more than one in three adults (35%) have obesity. However, before 2013, no state had an adult obesity prevalence at or above 35%. Currently, at least one in five adults (20%) in each U.S. state is living with obesity.

Increased focus on early diagnosis in the United States

One of the key contributors driving growth in the Pseudotumor cerebri market in the United States includes increasing focus on early diagnosis coupled with innovation of healthcare technologies. Diagnostic technologies of the US health care system are quite accessible and advanced, which play crucial roles in diagnosing Pseudotumor cerebri using neuroimaging like magnetic resonance imaging (MRI), and computed tomography (CT) scans among others. More focused awareness activities by healthcare associations and nonprofit organizations like the National Organization for Rare Disorders (NORD) are increasing awareness among both physicians and patients regarding symptoms such as headaches and vision changes. This early effort in intervention not only enhances the treatment outcomes of the condition but also creates a market in pharmaceutical products such as acetazolamide and surgical procedures including optic nerve sheath fenestration or cerebrospinal fluid shunting. Moreover, the strong focus on clinical trials coupled with the presence of approved therapies also drive the market development in the United States.

Increased Focus on Rare Diseases is driving high demand in Canada

In Canada, an important factor in the development of the Pseudotumor cerebri market is the growing focus on the support of rare diseases through state healthcare programs. Since Canada has a public health services system, patients with Pseudotumor cerebri receive diagnostics and treatment services without financial hurdles that assist in timely intervention. In addition, the increase in the screening of obesity-related conditions such as Pseudotumor cerebri in Canada has been fueled by the country’s focus on the obesity issue as a public health threat. Social marketing for weight loss and improved lifestyle has increased awareness of diseases associated with obesity leading to early identification and intervention. Moreover, the research community in Canada contributes to interdisciplinary international clinical trial participation in the development of varied new therapeutics, which allows the Canadian market to be supplied with improved treatment methods. Altogether these factors contribute to the expansion of the Pseudotumor cerebri market in Canada.

Click here to view the Report Description & TOC : https://univdatos.com/reports/Pseudotumor-Cerebri-Market

Conclusion

In conclusion, factors, such as increasing obesity cases, growing focus on early diagnosis, and rare diseases in the countries of North America are accelerating the growth of the Pseudotumor cerebri market in this region. Moreover, the United States has a well-developed healthcare infrastructure and technologically advanced diagnostics that encourage the treatment of Pseudotumor cerebri.

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/